Serum free light chain assays not total light chain assays are the standard of care to assess Monoclonal Gammopathies - ScienceDirect
The Answer, My Friend, is Flowing in the Blood: How to Monitor Treatment Response in Myeloma
Serum free light chain assessment in monoclonal gammopathy and kidney disease | Nature Reviews Nephrology
Kappa free light chain index as a diagnostic biomarker in multiple sclerosis: A real‐world investigation - Rosenstein - 2021 - Journal of Neurochemistry - Wiley Online Library
UHL GP NEWS
Polyclonal serum free light chain elevation is associated with increased risk of monoclonal gammopathies | Blood Cancer Journal